journal article·2024-06Open access

Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization

Yuan Su, Si Li, Xin Li, Jing‐Ying Zhou, Vraj P. Chauhan, Meng Li, Ya‐Hui Su, Chun‐Mei Liu, Yi‐Fei Ren, Wu Yin, Jeffrey D. Rimer, Ting Cai

Advanced Science· Volume 11· Issue 21

Abstract

Abstract Kidney stones are a pervasive disease with notoriously high recurrence rates that require more effective treatment strategies. Herein, tartronic acid is introduced as an efficient inhibitor of calcium oxalate monohydrate (COM) crystallization, which is the most prevalent constituent of human kidney stones. A combination of in situ experimental techniques and simulations are employed to compare the inhibitory effects of tartronic acid with those of its molecular analogs. Tartronic acid exhibits an affinity for binding to rapidly growing apical surfaces of COM crystals, thus setting it apart from other inhibitors such as citric acid, the current preventative treatment for kidney stones. Bulk crystallization and in situ atomic force microscopy (AFM) measurements confirm the mechanism by which tartronic acid interacts with COM crystal surfaces and inhibits growth. These findings are consistent with in vivo studies that reveal the efficacy of tartronic acid is similar to that of citric acid in mouse models of hyperoxaluria regarding their inhibitory effect on stone formation and alleviating stone‐related physical harm. In summary, these findings highlight the potential of tartronic acid as a promising alternative to citric acid for the management of calcium oxalate nephropathies, offering a new option for clinical intervention in cases of kidney stones.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Kidney Stones and Urolithiasis Treatments · Dermatological and Skeletal Disorders · Clay minerals and soil interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics China Pharmaceutical University Nanjing 211198 China

Department of Pharmaceutical Engineering China Pharmaceutical University Nanjing 211198 China

Department of Chemical and Biomolecular Engineering University of Houston Houston TX 77204 USA

The State Key Lab of Pharmaceutical Biotechnology, College of Life Science Nanjing University Nanjing 210036 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · Welch Foundation

References (73)

Show source-provided references
1. 10.1056/NEJMcp100101110.1056/NEJMcp1001011 ↗
2. 10.1056/NEJMra160161110.1056/NEJMra1601611 ↗
3. 10.1038/nrrheum.2015.12510.1038/nrrheum.2015.125 ↗
4. 10.1021/cm402552v10.1021/cm402552v ↗
5. 10.1016/S0140-6736(06)68071-910.1016/S0140-6736(06)68071-9 ↗
6. 10.1038/s41585-021-00469-x10.1038/s41585-021-00469-x ↗
7. 10.1038/s41581-020-00392-110.1038/s41581-020-00392-1 ↗
8. 10.1038/s41585-020-0332-x10.1038/s41585-020-0332-x ↗
9. 10.2113/GSELEMENTS.3.6.41510.2113/GSELEMENTS.3.6.415 ↗
10. 10.1038/nrneph.2017.1010.1038/nrneph.2017.10 ↗
11. 10.1016/j.ekir.2021.09.00310.1016/j.ekir.2021.09.003 ↗
12. 10.1038/ki.2013.25110.1038/ki.2013.251 ↗
13. 10.1038/ncpuro048010.1038/ncpuro0480 ↗
14. 10.1136/bmj.i5210.1136/bmj.i52 ↗
15. 10.1073/pnas.070965210510.1073/pnas.0709652105 ↗
16. 10.1126/science.119196810.1126/science.1191968 ↗
17. 10.1038/nature1906210.1038/nature19062 ↗
18. 10.1021/ja410623q10.1021/ja410623q ↗
19. 10.1073/pnas.170012511410.1073/pnas.1700125114 ↗
20. 10.1038/s41586-019-1918-410.1038/s41586-019-1918-4 ↗
21. 10.1039/D3CE00192J10.1039/D3CE00192J ↗
22. 10.1021/cr078274t10.1021/cr078274t ↗
23. 10.1038/s42003-023-05046-z10.1038/s42003-023-05046-z ↗
24. 10.1073/pnas.150102311210.1073/pnas.1501023112 ↗
25. 10.1021/acs.cgd.3c0061610.1021/acs.cgd.3c00616 ↗
26. 10.1021/acs.cgd.1c0097110.1021/acs.cgd.1c00971 ↗
27. 10.1016/j.apsusc.2022.15335510.1016/j.apsusc.2022.153355 ↗
28. 10.1038/s41467-023-35924-310.1038/s41467-023-35924-3 ↗
29. 10.1073/pnas.030790010010.1073/pnas.0307900100 ↗
30. 10.1021/ja074561310.1021/ja0745613 ↗
31. 10.1073/pnas.170815311410.1073/pnas.1708153114 ↗
32. 10.1021/acs.cgd.7b0060810.1021/acs.cgd.7b00608 ↗
33. 10.1038/s43246-022-00329-010.1038/s43246-022-00329-0 ↗
34. 10.1002/advs.20190333710.1002/advs.201903337 ↗
35. 10.1038/s42003-022-03750-w10.1038/s42003-022-03750-w ↗
36. 10.1016/j.urology.2016.03.03010.1016/j.urology.2016.03.030 ↗
37. 10.1021/ja043591s10.1021/ja043591s ↗
38. 10.1021/acs.cgd.8b0094510.1021/acs.cgd.8b00945 ↗
39. 10.1021/la301898510.1021/la3018985 ↗
40. 10.1021/jp804282u10.1021/jp804282u ↗
41. 10.2174/157018005376511010.2174/1570180053765110 ↗
42. 10.4155/fmc.13.15110.4155/fmc.13.151 ↗
43. 10.1210/endo-47-4-30210.1210/endo-47-4-302 ↗
44. 10.1016/j.lfs.2020.11824010.1016/j.lfs.2020.118240 ↗
45. 10.1038/187792a010.1038/187792a0 ↗
46. 10.1038/189147b010.1038/189147b0 ↗
47. 10.1016/0006-3002(62)90057-410.1016/0006-3002(62)90057-4 ↗
48. 10.1021/cg005553010.1021/cg0055530 ↗
49. 10.1097/MNH.000000000000033010.1097/MNH.0000000000000330 ↗
50. 10.1016/j.jcrysgro.2022.12683910.1016/j.jcrysgro.2022.126839 ↗
51. 10.1021/cg070427i10.1021/cg070427i ↗
52. 10.1046/j.1523-1755.1999.00682.x10.1046/j.1523-1755.1999.00682.x ↗
53. 10.1021/jacs.9b1090510.1021/jacs.9b10905 ↗
54. 10.1007/s00240-007-0082-810.1007/s00240-007-0082-8 ↗
55. 10.1053/j.ajkd.2021.03.02610.1053/j.ajkd.2021.03.026 ↗
56. 10.1016/S0022-5347(05)64621-610.1016/S0022-5347(05)64621-6 ↗
57. 10.1021/la060897z10.1021/la060897z ↗
58. 10.1007/s00240-019-01125-110.1007/s00240-019-01125-1 ↗
59. 10.1073/pnas.152410911310.1073/pnas.1524109113 ↗
60. 10.1016/j.cryobiol.2006.06.00610.1016/j.cryobiol.2006.06.006 ↗
61. 10.1021/pr200303810.1021/pr2003038 ↗
62. 10.1371/journal.pone.007307610.1371/journal.pone.0073076 ↗
63. 10.1002/jca.2122210.1002/jca.21222 ↗
64. 10.1359/jbmr.1997.12.6.97210.1359/jbmr.1997.12.6.972 ↗
65. 10.1039/C9LC00061E10.1039/C9LC00061E ↗
66. 10.1021/acs.chemmater.0c0318010.1021/acs.chemmater.0c03180 ↗
67. Phillips R. · Cochrane Database Syst. Rev. · 2015 · 2015
68. 10.1089/08927790275371609810.1089/089277902753716098 ↗
69. 10.1016/j.juro.2008.11.01410.1016/j.juro.2008.11.014 ↗
70. 10.1007/s00240-023-01468-w10.1007/s00240-023-01468-w ↗
71. 10.1016/j.juro.2018.07.03910.1016/j.juro.2018.07.039 ↗
72. 10.1016/S0022-5347(17)35888-310.1016/S0022-5347(17)35888-3 ↗
73. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗